We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 8,260

Food court grants summary judgment in class action targeting “no sugar added” label

  • Mayer Brown LLP
  • -
  • USA
  • -
  • March 4 2015

As readers of this blog are well aware, manufacturers and retailers have faced a tidal wave of consumer class actions alleging false advertising in

Ascertainability saps plaintiffs’ energy in dietary supplement class action

  • Sheppard Mullin Richter & Hampton LLP
  • -
  • USA
  • -
  • March 4 2015

In the recent decision Mirabella v. Vital Pharmaceuticals, Inc., Case No. 12-62086-CIV-ZLOCH (S.D. Fl. Feb. 27, 2015) the plaintiffs attempted, but

CPSC penalties to increase beyond “cost of doing business”

  • Morrison & Foerster LLP
  • -
  • USA
  • -
  • March 3 2015

At the end of last year, we reported that the Consumer Products Safety Commission (CPSC) issued $12.2 million in civil penalties in 2014, more than

Effectively using a lightning rod

  • Arnall Golden Gregory LLP
  • -
  • USA
  • -
  • March 3 2015

It’s been a whilemy apologies! Waiting at an airport on a winter weather delay has me thinking of all the times I’ve been delayed because of summer

FDA issues Warning Letter to L’Oreal for skin pigmentation claims

  • Arent Fox LLP
  • -
  • USA
  • -
  • March 3 2015

Recently, the US Food and Drug Administration (FDA) issued a Warning Letter to L'Oreal USA for marketing its cosmetic products, "Rosalic AR Intense"

Reaching a state of comfortably numb: FDA intends to relax enforcement for certain types of medical devices

  • Arnall Golden Gregory LLP
  • -
  • USA
  • -
  • March 2 2015

When one reads the final guidance, "Medical Device Data Systems MDDS, Medical Image Storage Devices, and Medical Image Communications Devices," the

Lawmakers solicit public feedback on legislation intended to expand patients’ access to drugs, devices and other treatments

  • Arnall Golden Gregory LLP
  • -
  • USA
  • -
  • March 2 2015

On January 27, 2015 the House of Representatives Committee on Energy and Commerce released a discussion draft of a bill entitled, "21st Century Cures

First Circuit finds federal preemption of state tort claims that conflict with a medication’s FDA-approved labeling & warnings

  • King & Spalding LLP
  • -
  • USA
  • -
  • March 2 2015

An opinion issued by the U.S. Court of Appeals for the First Circuit on February 20, 2015 held that the Federal Food, Drug, and Cosmetic Act ("FDCA"

"Comcast" continues to change the damages class

  • Arnold & Porter LLP
  • -
  • USA
  • -
  • March 2 2015

The impact of the Supreme Court's Comcast decision on certification of class actions, first discussed here, continues to be felt across courtrooms

Statistics are still unnecessary for a label to be adequate

  • Cozen O'Connor
  • -
  • USA
  • -
  • March 2 2015

We've already blogged about Judge Sweet's decision last November in the Cymbalta litigation and why it was important. McDowell v. Eli Lilly, 2014 WL